KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ORPN
Delisted

Bio Blast Pharma Ltd. Stock Price (Quote)

$5.24
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $5.24 $5.24 Friday, 27th May 2022 ORPN stock ended at $5.24. During the day the stock fluctuated 0% from a day low at $5.24 to a day high of $5.24.
90 days $5.10 $5.38
52 weeks $4.76 $13.95

Historical Bio Blast Pharma Ltd. prices

Date Open High Low Close Volume
Sep 24, 2019 $39.88 $40.14 $37.75 $37.75 8 737
Sep 23, 2019 $37.42 $44.90 $37.42 $39.42 50 627
Sep 20, 2019 $36.24 $36.80 $36.00 $36.77 6 374
Sep 19, 2019 $35.79 $36.73 $35.32 $36.39 22 937
Sep 18, 2019 $34.70 $34.80 $34.19 $34.80 2 257
Sep 17, 2019 $33.30 $33.80 $33.30 $33.80 8 835
Sep 16, 2019 $32.10 $36.24 $31.01 $33.20 31 091
Sep 13, 2019 $30.60 $32.49 $30.60 $31.98 7 279
Sep 12, 2019 $28.91 $32.70 $28.91 $30.97 15 341
Sep 11, 2019 $27.65 $28.91 $27.65 $28.91 3 718
Sep 10, 2019 $28.00 $28.20 $27.20 $28.20 6 583
Sep 09, 2019 $28.17 $28.17 $27.50 $28.15 2 205
Sep 06, 2019 $27.50 $27.88 $27.50 $27.80 4 045
Sep 05, 2019 $26.70 $27.90 $26.60 $27.87 5 177
Sep 04, 2019 $26.92 $27.50 $26.01 $27.50 4 446
Sep 03, 2019 $27.50 $27.90 $25.57 $26.57 14 988
Aug 30, 2019 $27.19 $28.20 $26.99 $27.89 5 623
Aug 29, 2019 $25.35 $27.51 $25.35 $27.40 4 918
Aug 28, 2019 $26.10 $26.20 $24.00 $26.10 6 588
Aug 27, 2019 $26.96 $26.96 $26.26 $26.90 5 130
Aug 26, 2019 $27.60 $27.60 $26.52 $26.75 6 882
Aug 23, 2019 $27.60 $27.70 $25.64 $27.50 7 639
Aug 22, 2019 $27.60 $27.72 $27.50 $27.72 3 205
Aug 21, 2019 $27.50 $27.94 $27.00 $27.94 4 771
Aug 20, 2019 $28.69 $28.78 $26.97 $28.20 6 106
Click to get the best stock tips daily for free!

About Bio Blast Pharma Ltd.

Bio Blast Pharma Ltd., a clinical development-stage biopharmaceutical company, focuses on the identification, licensing, acquisition, development, and commercialization clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. The company’s drug candidates under clinical or preclinical development includes Trehalose 90mg/mL IV solution, a mutant protein stabilizer and autophagy enhancer used for protein-based drugs ... ORPN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT